GTX INC. GTXI (NASDAQ)

$ 16.20
11/18/2008 20:09
Sponsored by
Click here!
Change: unch (unch%)
Volume: 231,750

Avg. Volume: 164732
P/E Ratio: 0
EPS (Annual): -1.41
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 36,330
Institutional Shareholders: 46.48%
Last: 16.20
Change: unch (unch%)
Prev. Close: 16.20
Open: 15.75
Day's Range: 15.61 - 16.25
52wk Range: 10.75 - 20.20
Market Value: 575,180
Beta: 1.07
12-month EPS Change: 0.00%
Total Return Last 12 Months: +9.69%
Total Return Last 3 Years: +54.32%
Total Return Last 5 Years: +21.94%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on GTXI
Alert me Subscribe

Sector Snap: Diabetes drug developers gain ground

(NEW YORK)A regulatory delay for Takeda Pharmaceuticals developing diabetes drug alogliptin helped boost shares of competitor Merck & Co. Monday, highlighting the competitive nature of diabe...READ MORE
Oct 13, 2008 11:59AM
Keywords: MRK, BMY, AMLN, NVO, GTXI, AZN, LLY

GTx cancer-related muscle loss drug meets goal

(MEMPHIS, Tenn.)GTx Inc. said Monday its experimental drug aimed at treating muscle loss in cancer patients met its main goal of improving lean body mass in a midstage study.READ MORE
Oct 13, 2008 9:58AM
Keywords: GTXI, MRK

GTx 2Q loss widens on R&D, administrative costs

(MEMPHIS, Tenn.)Biopharmaceutical company GTx Inc. said Tuesday its second-quarter loss widened due to higher research and development expenses and administrative costs.READ MORE
Aug 05, 2008 10:24AM
Keywords: GTXI

GTx study continues after safety review

(MEMPHIS, Tenn.)Biopharmaceutical company GTx Inc. said Monday it is continuing a late-stage study of its experimental prostate cancer drug after completing a planned safety review.READ MORE
Jul 28, 2008 8:25AM
Keywords: GTXI

GTx shares fall on prostate cancer drug trial

(NEW YORK)Shares of biopharmaceutical company GTx Inc. fell Friday after the company said a late-stage trial of its prostate cancer drug candidate needs to continue, precluding an early fili...READ MORE
May 23, 2008 5:21PM
Keywords: GTXI

Movers roundup: Suntech Power, Black Box

Among the stock activity stories for Friday, May 23, from AP Financial News: NEW YORK (AP)--Suntech Power Holdings Co. Ltd.'s American Depositary Shares rose Friday after the s...READ MORE
May 23, 2008 2:21PM
Keywords: STP, BBOX, VVUS, RCL, IXYS, GTXI

GTX's Prostate Cancer Treatment Will Complete Efficacy Analysis

(NEW YORK)GTx Inc. said on Friday its prostate cancer treatment will continue the late stage of its clinical trial as it did not bear the results that were expected. Shares of the company sl...READ MORE
May 23, 2008 1:57PM
Keywords: GTXI
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN INC. +9.80 56.34
GILEAD SCIENCES -3.90 45.22
CELGENE CORPORA -10.10 57.57
STEMCELLS INC. -61.50 1.13
BIOGEN IDEC INC -30.40 43.80